Cantor’s Eric Johnston joined CNBC’s Closing Bell Overtime to discuss his #bearish outlook on equities

Our next panel, “Take a Look at What’s in Store for Wet AMD & Related Diabetic Eye Diseases,” featured

Our final panel, “The Doctors’ Viewpoint: What to Focus on in the Eye Space for 2023+,” featured

Our next panel, “Do the Robot: A Discussion on How Leveraging Robots May Improve Surgical Outcomes,”

Our next panel, “Aesthetically Pleasing & Medically Necessary: Leading Aesthetic & Medical Dermatology

Our third panel, “Large TAM Takes Lead Role: Novel Tests in Specialized Markets,” featured John Aballi,

Our next panel, “Distraction or Destruction?: What’s New/Next in the Industry” featured Niquette

Our next panel, “Where to Invest – Let’s Talk About What’s Topical in 2023+,” featured Dr.

Thank you to all who joined Cantor’s Medical & Aesthetic Dermatology, Ophthalmology & MedTech/Diagnostic

Our second panel, “Hit or Miss: Companies with 2023 Readouts & Launches to Keep in Focus,” featured

Cantor's Eric Johnston joined CNBC’s Closing Bell Overtime to discuss his #bearish equity view and